News

Modified personalized cancer vaccine generates powerful immune response
Results of a Dana-Farber Cancer Institute-initiated phase 1 clinical trial for patients with melanoma show that an updated ...
Arcus Biosciences' Pancreatic Cancer Treatment Gets Orphan Drug Status
Arcus Biosciences announced that the Food and Drug Administration has granted its pancreatic cancer treatment, quemliclustat, with an orphan drug designation. The company said it expects its ongoing ...
Revolution Medicines’ Daraxonrasib Granted FDA Breakthrough Therapy Designation for Pancreatic Cancer with KRAS G12 Mutations
Revolution Medicines Inc. (NASDAQ:RVMD) is one of the most promising stocks according to Wall Street analysts. On June 23, ...
Just The News3d
COVID boosters correlate with worse survival rates for cancer with third-most deaths: study
Trump administration policy tug-of-war between big medical groups that want COVID vaccines back on CDC schedule for healthy ...
New synthetic molecule targets and kills breast and pancreatic cancers in as few as three doses
Scientists have developed a new molecule that can deliver powerful immune-activating treatment directly to cancer cells, ...